A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 75
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : PS80
Long Form : polysorbate 80
No. Year Title Co-occurring Abbreviation
2019 A Mechanistic Understanding of Polysorbate 80 Oxidation in Histidine and Citrate Buffer Systems-Part 2. ---
2019 Edetate Disodium as a Polysorbate Degradation and Monoclonal Antibody Oxidation Stabilizer. mAb
2019 Factors Influencing Polysorbate's Sensitivity Against Enzymatic Hydrolysis and Oxidative Degradation. PS20
2019 Inhibitory effects of polysorbate 80 on MRSA biofilm formed on different substrates including dermal tissue. MRSA
2019 On-line coupling of hydrophobic interaction column with reverse phase column -charged aerosol detector/mass spectrometer to characterize polysorbates in therapeutic protein formulations. CAD, HIC, MS, RPLC, SEC
2018 Microstructural Distinction of Electrospun Nanofibrous Drug Delivery Systems Formulated with Different Excipients. AFM, HP-beta-CD, NMR, PALS
2018 Preparation and In vitro Evaluation of Efficacy and Toxicity of Polysorbate 80-coated Bovine Serum Albumin Nanoparticles containing Amphotericin B. AmB, BSA
2018 The absence of SigX results in impaired carbon metabolism and membrane fluidity in Pseudomonas aeruginosa. CCR, LB
2017 Comparison of adverse events following injection of original or generic docetaxel for the treatment of breast cancer. PEG
10  2017 Core-Cross-Linked Nanoparticles Reduce Neuroinflammation and Improve Outcome in a Mouse Model of Traumatic Brain Injury. NPs, ROS, TBI
11  2017 Effect of Polysorbate 20 and Polysorbate 80 on the Higher-Order Structure of a Monoclonal Antibody and Its Fab and Fc Fragments Probed Using 2D Nuclear Magnetic Resonance Spectroscopy. mAb, NMR, PS20
12  2017 Knockout of a difficult-to-remove CHO host cell protein, lipoprotein lipase, for improved polysorbate stability in monoclonal antibody formulations. CHO, HCP, LPL, PS-20
13  2016 Acute cytotoxic effects of marketed ophthalmic formulations on human corneal epithelial cells. BAC, HCE-T
14  2016 Cytotoxicity and apoptotic gene expression in an in vitro model of the blood-brain barrier following exposure to poly(butylcyanoacrylate) nanoparticles. DOX, NPs, PBCA
15  2016 Glioma-targeted superparamagnetic iron oxide nanoparticles as drug-carrying vehicles for theranostic effects. Ms
16  2016 Nanoencapsulation of gallic acid and evaluation of its cytotoxicity and antioxidant activity. PLGA
17  2016 Polysorbates prevent biofilm formation and pathogenesis of Escherichia coli O104:H4. FDA, PS20
18  2016 Quantitative and Mechanistic Assessment of Model Lipophilic Drugs in Micellar Solutions in the Transport Kinetics Across MDR1-MDCK Cell Monolayers. AP, BL, P-gp
19  2016 Rapamycin Loaded Solid Lipid Nanoparticles as a New Tool to Deliver mTOR Inhibitors: Formulation and in Vitro Characterization. cryo-TEM, DLS, DSC, mTOR, mTORC1, NMR, RP, Rp-SLN, WAXS
20  2016 Stabilization of a human recombinant factor VIII by poloxamer 188 in relation to polysorbate 80. rFVIII
21  2015 Competitive adsorption of monoclonal antibodies and nonionic surfactants at solid hydrophobic surfaces. ---
22  2015 Distribution of beta-carotene-encapsulated polysorbate 80-coated poly(D, L-lactide-co-glycolide) nanoparticles in rodent tissues following intravenous administration. BC, BC-PLGA-NPs, NPs, PLGA, UV
23  2015 Effect of surfactants or a water soluble polymer on the crystal transition of clarithromycin during a wet granulation process. CAM
24  2015 Fatty acid composition analysis in polysorbate 80 with high performance liquid chromatography coupled to charged aerosol detection. CAD, FA
25  2015 Improved neuroprotective effects of resveratrol-loaded polysorbate 80-coated poly(lactide) nanoparticles in MPTP-induced Parkinsonism. MPTP, PD, RVT
26  2015 Nanotoxicity of poly(n-butylcyano-acrylate) nanoparticles at the blood-brain barrier, in human whole blood and in vivo. BBB, PBCA
27  2015 Predicting critical micelle concentration and micelle molecular weight of polysorbate 80 using compendial methods. CMC, FRC, HLB
28  2015 The influence of polysorbate 80 on the radiochemical synthesis of a PET tracer in the FASTlab. FOX, MCR
29  2014 An investigation into the parameters affecting preparation of polybutyl cyanoacrylate nanoparticles by emulsion polymerization. ---
30  2014 Control of protein particle formation during ultrafiltration/diafiltration through interfacial protection. HP-beta-CD, UF/DF
31  2014 Ester hydrolysis of polysorbate 80 in mAb drug product: evidence in support of the hypothesized risk after the observation of visible particulate in mAb formulations. PEG
32  2014 Influence of different additives and their concentrations on corneal toxicity and antimicrobial effect of benzalkonium chloride. BAC, HCO-40
33  2014 Influence of drug formulation on OATP1B-mediated transport of paclitaxel. ---
34  2014 Searching for life on Mars: degradation of surfactant solutions used in organic extraction experiments. PDMSHEPMS
35  2014 Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood-brain barrier. BBB, MMPs, NPs, PLGA, TIMP-1
36  2013 Computational prediction of drug solubility in lipid based formulation excipients. LBFs
37  2013 Multifunctional terpolymeric MRI contrast agent with superior signal enhancement in blood and tumor. DOX, DTPA, MAA
38  2013 The effects of excipients on protein aggregation during agitation: an interfacial shear rheology study. KGF-2
39  2013 The permeability of puerarin loaded poly(butylcyanoacrylate) nanoparticles coated with polysorbate 80 on the blood-brain barrier and its protective effect against cerebral ischemia/reperfusion injury. BBB, PBCN, Pue
40  2012 Characterization of polysorbate 80 with liquid chromatography mass spectrometry and nuclear magnetic resonance spectroscopy: specific determination of oxidation products of thermally oxidized polysorbate 80. ESI, POE
41  2012 Disposition kinetics of taxanes in peritoneal dissemination. CrEL
42  2012 Hypersensitivity reaction to human papillomavirus vaccine due to polysorbate 80. ---
43  2012 Pseudomonas aeruginosa exopolysaccharide Psl promotes resistance to the biofilm inhibitor polysorbate 80. ---
44  2011 Dissolution and spectrophotometric determination of astaxanthin in aqueous solutions. SLS
45  2011 Effect of bile on the oral absorption of halofantrine in polyethylene glycol 400 and polysorbate 80 formulations dosed to bile duct cannulated rats. BDC, PEG 400
46  2011 Effects of non-ionic surfactants on cytochrome P450-mediated metabolism in vitro. CMC, Cr RH 40, CrEL
47  2011 New association of surfactants for the production of food and cosmetic nanoemulsions: preliminary development and characterization. ---
48  2011 Stability of the non-ionic surfactant polysorbate 80 investigated by HPLC-MS and charged aerosol detector. CAD, MSD
49  2011 Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity. BBB, PBCA-NP, TEER
50  2010 Assessment of hydroxypropyl methylcellulose, propylene glycol, polysorbate 80, and hydroxypropyl-beta-cyclodextrin for use in developmental and reproductive toxicology studies. DART, GD, HP-beta-CD, MC, PG
51  2010 Comprehensive investigation of hydroxypropyl methylcellulose, propylene glycol, polysorbate 80, and hydroxypropyl-beta-cyclodextrin for use in general toxicology studies. HP-beta-CD, PG
52  2010 Development of a size-exclusion HPLC method with evaporative light-scattering detection for the quantitation of polysorbate 80 in Houttuynia cordata injection. ELSD
53  2010 Effects of non-ionic surfactants on in vitro triglyceride digestion and their susceptibility to digestion by pancreatic enzymes. CMC, Cr RH 40, CrEL, SEDDS
54  2010 Effects of polysorbate 80 on the in-vitro precipitation and oral bioavailability of halofantrine from polyethylene glycol 400 formulations in rats. PEG 400
55  2009 Polysorbate 80 inhibition of Pseudomonas aeruginosa biofilm formation and its cleavage by the secreted lipase LipA. ---
56  2008 An evaluation of the relative roles of the unstirred water layer and receptor sink in limiting the in-vitro intestinal permeability of drug compounds of varying lipophilicity. AAG, BSA, CIN, DIA, MAN, UWL
57  2008 Chloramphenicol-incorporated poly lactide-co-glycolide (PLGA) nanoparticles: formulation, characterization, technetium-99m labeling and biodistribution studies. CHL, NPs, PLGA, PVA
58  2008 Evaluation of developmental neurotoxicity of polysorbate 80 in rats. PNDs
59  2007 Evaluation of hydroperoxides in common pharmaceutical excipients. HPC, HPO, MCG, PEG
60  2007 Impact of cremophor-EL and polysorbate-80 on digoxin permeability across rat jejunum: delineation of thermodynamic and transporter related events using the reciprocal permeability approach. Cr-EL, DIG, sm
61  2007 Long-circulating poly(ethylene glycol)-coated emulsions to target solid tumors. DSPE, ESM, HSPC
62  2006 Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats. BBB, DOX, EPR effect, NP, RES
63  2006 Permeability assessment of poorly water-soluble compounds under solubilizing conditions: the reciprocal permeability approach. ANT, CIN, DIA, NAP, PRO
64  2005 Stabilization of human papillomavirus virus-like particles by non-ionic surfactants. HPV, VLPs
65  2005 [Antiamnesic activity of nerve growth factor adsorbed on poly(butyl) cyanoacrylate nanoparticles coated with polysorbate-80]. NGF, PAR, PBCA
66  2004 Disposition kinetics of taxanes after intraperitoneal administration in rats and influence of surfactant vehicles. CrEL
67  2002 Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol. KT, MA, PGDS
68  2000 Diffusion of n-butyl-p-aminobenzoate (BAB), lidocaine and bupivacaine through the human dura-arachnoid mater in vitro. BAB, PEG 3350
69  1998 Effect of composition on biological fate of oil particles after intravenous injection of O/W lipid emulsions. DS500, EYP, LSI, O/W, PL, RES, SO, TG
70  1994 Enhanced rectal absorption of itazigrel formulated with polysorbate 80 micelle vehicle in rat: role of co-administered esterase. ---
71  1994 Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility. LDH, NP-POE, SDS, TC, TDC
72  1989 Enhancement of oral bioavailability of d-alpha-tocopherol acetate by lecithin-dispersed aqueous preparation containing medium-chain triglycerides in rats. ---
73  1989 Enhancing effect of medium-chain triglycerides on intestinal absorption of d-alpha-tocopherol acetate from lecithin-dispersed preparations in the rat. MCTG, PC, VE
74  1985 Effect of synthetic surfactants on drug absorption in the presence of a physiologic surfactant, sodium taurocholate, in rats. CTAB, SLS, STC
75  1983 Intestinal absorption of dl-alpha-tocopherol from bile salts and polysorbate 80 micellar solutions in rat. STC, STDC